UAB Center for Neurodegeneration and Experimental Therapeutics: Difference between revisions
Jump to navigation
Jump to search
(Created page with "The '''UAB Center for Neurodegeneration and Experimental Therapeutics''' ('''CNET''') is a research center at the UAB Heersink School of Medicine. The center was created i...") |
No edit summary |
||
| Line 7: | Line 7: | ||
* [[Erik Roberson]] and [[Andy West]] (co-directors), 2013–2018 | * [[Erik Roberson]] and [[Andy West]] (co-directors), 2013–2018 | ||
* [[Erik Roberson]] | * [[Erik Roberson]] | ||
==External links== | |||
* [https://www.uab.edu/medicine/cnet/ UAB Center for Neurodegeneration and Experimental Therapeutics] at UAB.edu | |||
[[Category:UAB School of Medicine|Center for Neurodegeneration and Experimental Therapeutics]] | [[Category:UAB School of Medicine|Center for Neurodegeneration and Experimental Therapeutics]] | ||
[[Category:2006 establishments]] | [[Category:2006 establishments]] | ||
Revision as of 17:23, 11 November 2022
The UAB Center for Neurodegeneration and Experimental Therapeutics (CNET) is a research center at the UAB Heersink School of Medicine. The center was created in 2006 as a home for research led by David Standaert. It was chartered in 2007 and now encompasses 13 laboratories and 50 research staff working at the Civitan International Research Center and the Shelby Biomedical Research Building.
The Center for Neurodegeneration and Experimental Therapeutics conducts research into a variety of diseases including Alzheimer's disease, Parkinson's disease, frontotemporal dementia, dementia with Lewy bodies, progressive supranuclear palsy, corticobasal degeneration, Huntington's disease, multiple system atrophy, and ALS.
Directors
- David Standaert, 2006–2013
- Erik Roberson and Andy West (co-directors), 2013–2018
- Erik Roberson